Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study

doi:10.5492/wjccm.v13.i3.96882

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-5)

Sum=0

Sep 9, 2024 (publication date) through Aug 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Crit Care Med. Sep 9, 2024; 13(3): 96882
Published online Sep 9, 2024. doi: 10.5492/wjccm.v13.i3.96882

Table 4 Predictors of mortality in coronavirus disease 2019 patients by multivariable logistic regression

Risk factor	Adjusted odds ratio (95%CI)	P value
Age	1.21 (1.06-1.39)	0.005^a
Sex	-	0.742
Diabetes	-	0.057
Ischemic heart disease	-	0.686
Duration of antihypertensive therapy	0.69 (0.51-0.94)	0.008^a
ACEI/ARB	-	0.997
Calcium channel blockers	-	0.996
ACEI/ARB + calcium channel blockers	-	0.997
Beta-blockers	-	0.998
Hemoglobin	-	0.465
Neutrophil/lymphocyte ratio	-	0.071
ESR	0.92 (0.87-0.97)	0.005^a
hs-CRP	0.97 (0.95-0.99)	0.014^a
Blood urea		0.095
Serum ferritin	-	0.081
Serum interleukin 6	0.97 (0.96-0.99)	0.009^a

^aP< 0.05.

ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CI: Confidence interval; ESR: Erythrocyte sedimentation rate; hs-CRP: High-sensitivity C-reactive protein.

Citation: Varatharajan S, Bohra GK, Bhatia PK, Khichar S, Meena M, Palanisamy N, Gaur A, Garg MK. Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study. World J Crit Care Med 2024; 13(3): 96882
URL: https://www.wjgnet.com/2220-3141/full/v13/i3/96882.htm
DOI: https://dx.doi.org/10.5492/wjccm.v13.i3.96882